Back
Roundhill GLP-1 & Weight Loss ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison
Sell
49
OZEM
Roundhill GLP-1 & Weight Loss ETF
Last Price:
26.64
Seasonality Move:
--
Buy
52
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
28.00
Seasonality Move:
4.46%
Sell
49
Roundhill GLP-1 & Weight Loss ETF (OZEM)
is a Sell
Is Roundhill GLP-1 & Weight Loss ETF a Buy, Sell or Hold?
- The current Roundhill GLP-1 & Weight Loss ETF [OZEM] share price is $26.50. The Score for OZEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- OZEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Buy
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.29. The Score for FTXH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- FTXH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OZEM Stock Price Chart
What is Roundhill GLP-1 & Weight Loss ETF's stock price today?
-
The Roundhill GLP-1 & Weight Loss ETF share price today is $26.50
The current trend is relatively stagnant and OZEM is experiencing slight buying pressure.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing slight buying pressure.
OZEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 47.43 | Sell |
| Chaikin Money Flow: | 8577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.83 - 27.93) | Sell |
| Bollinger Bands (100): | (26.65 - 28.59) | Sell |
FTXH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 51.91 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.63 - 28.71) | Buy |
| Bollinger Bands (100): | (28.02 - 29.14) | Sell |
OZEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.57 | Buy |
| 20-day SMA: | 26.55 | Sell |
| 50-day SMA: | 27.55 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 26.02 | Buy |
| 20-day EMA: | 26.5 | Buy |
| 50-day EMA: | 27.15 | Sell |
| 200-day EMA: | 10.63 | Buy |
FTXH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.65 | Buy |
| 20-day SMA: | 28.18 | Buy |
| 50-day SMA: | 28.46 | Sell |
| 200-day SMA: | 27.85 | Buy |
| 8-day EMA: | 27.99 | Buy |
| 20-day EMA: | 28.11 | Buy |
| 50-day EMA: | 28.33 | Sell |
| 200-day EMA: | 27.88 | Buy |
Roundhill GLP-1 & Weight Loss ETF Earnings Growth & OZEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roundhill GLP-1 & Weight Loss ETF Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||